var data={"title":"Tuberculous pleural effusion","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Tuberculous pleural effusion</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/contributors\" class=\"contributor contributor_credentials\">Michael D Frye, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/contributors\" class=\"contributor contributor_credentials\">John T Huggins, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/contributors\" class=\"contributor contributor_credentials\">C Fordham von Reyn, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;May 05, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Tuberculous pleural effusion is the second most common form of extrapulmonary tuberculosis (after lymphatic involvement) and is the most common cause of pleural effusion in areas where tuberculosis is endemic [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/1-5\" class=\"abstract_t\">1-5</a>]. Tuberculous pleural effusion is synonymous with the term tuberculous pleurisy.</p><p>Issues related to the evaluation and management of tuberculous pleural effusions will be reviewed here. Issues related to pulmonary tuberculosis are discussed separately. (See <a href=\"topic.htm?path=treatment-of-drug-susceptible-pulmonary-tuberculosis-in-hiv-uninfected-adults\" class=\"medical medical_review\">&quot;Treatment of drug-susceptible pulmonary tuberculosis in HIV-uninfected adults&quot;</a> and <a href=\"topic.htm?path=treatment-of-pulmonary-tuberculosis-in-hiv-infected-adults-initiation-of-therapy\" class=\"medical medical_review\">&quot;Treatment of pulmonary tuberculosis in HIV-infected adults: Initiation of therapy&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3576050\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span></p><p class=\"headingAnchor\" id=\"H2891054917\"><span class=\"h2\">Overview</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Tuberculous pleural effusions can occur in association with reactivation disease or primary tuberculosis (TB) [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/4,6-9\" class=\"abstract_t\">4,6-9</a>]. In adults, most often they occur due to reactivation disease [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/7,8\" class=\"abstract_t\">7,8</a>]; in children, most often they occur in the setting of primary disease [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/9\" class=\"abstract_t\">9</a>].</p><p>Development of tuberculous pleural effusion occurs most commonly as a result of delayed hypersensitivity reaction to mycobacteria or mycobacterial antigens in the pleural space [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/10\" class=\"abstract_t\">10</a>]. Less commonly, tuberculous pleural effusion develops when a subpleural focus of disease ruptures into the pleural space [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/11\" class=\"abstract_t\">11</a>].</p><p>Patients with tuberculous pleural effusion usually have an acute febrile illness with nonproductive cough (94 percent) and pleuritic chest pain (78 percent) [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/12\" class=\"abstract_t\">12</a>]. Night sweats, chills, weakness, dyspnea, and weight loss can also occur. The peripheral white blood cell count is typically normal [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/12\" class=\"abstract_t\">12</a>].</p><p>Tuberculous pleural effusions are usually unilateral, small to moderate in size, and self-limited [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/6\" class=\"abstract_t\">6</a>]. In HIV-uninfected patients, tuberculous pleural effusions occur slightly more frequently on the right side than the left (55 versus 45 percent) [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/13,14\" class=\"abstract_t\">13,14</a>] and occupy less than one-third of the hemithorax in 82 percent of cases [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/13\" class=\"abstract_t\">13</a>]. In HIV-infected patients, tuberculous pleural effusions are equally distributed on the left and right; a miliary pattern is observed in 7 to 10 percent of cases. Adenopathy occurs in 5 to 18 percent of cases [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/15\" class=\"abstract_t\">15</a>].</p><p>Chest radiography demonstrates parenchymal disease in association with pleural effusion in up to 50 percent of HIV-uninfected patients [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/4\" class=\"abstract_t\">4</a>] and 73 percent of HIV-infected patients [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/16,17\" class=\"abstract_t\">16,17</a>]. Among HIV-uninfected patients, the upper lobe is involved in approximately 75 percent of cases (suggestive of reactivation TB), and the lower lobe is involved in approximately 25 percent of cases (suggesting primary disease). Among HIV-infected patients, in contrast, parenchymal disease occurs most often in the lower lobe (75 percent) [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/15\" class=\"abstract_t\">15</a>]. The pleural effusion virtually always occurs on the same side as the parenchymal infiltrate [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/12\" class=\"abstract_t\">12</a>].</p><p>Computed tomography is more sensitive than chest radiography; it demonstrates parenchymal disease in over 80 percent of cases, supporting the theory of spread to the pleura from a subpleural focus (<a href=\"image.htm?imageKey=PULM%2F63772\" class=\"graphic graphic_diagnosticimage graphicRef63772 \">image 1</a>) [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/18\" class=\"abstract_t\">18</a>]. In patients without apparent parenchymal involvement, pleural disease may develop via hematogenous spread following primary infection.</p><p>Tuberculous pleural effusion can progress to tuberculous empyema, characterized by purulent fluid containing numerous organisms. Tuberculous empyema can also develop via extension of infection from thoracic lymph nodes or a subdiaphragmatic focus, via hematogenous spread, or in the setting of pneumothorax. Tuberculous empyema is often associated with a thickened, scarred, and calcified pleura (<a href=\"image.htm?imageKey=ID%2F106792\" class=\"graphic graphic_diagnosticimage graphicRef106792 \">image 2</a>) [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/19,20\" class=\"abstract_t\">19,20</a>].</p><p class=\"headingAnchor\" id=\"H3345958506\"><span class=\"h2\">HIV coinfection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>HIV-infected patients are at increased risk for progression from latent TB infection to active TB disease, and pleural involvement is common in the presence of HIV coinfection [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/14,21,22\" class=\"abstract_t\">14,21,22</a>]. Clinical manifestations of tuberculous pleural effusion in the setting of HIV infection include fever (85 percent), cough (77 percent), chest pain (36 percent), dyspnea (23 percent), and weight loss &gt;2 kg (74 percent) [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/16,17,23\" class=\"abstract_t\">16,17,23</a>]. Additional signs and symptoms such as night sweats, diarrhea, hepatosplenomegaly, and lymphadenopathy are also more common in HIV-infected patients.</p><p class=\"headingAnchor\" id=\"H3577153\"><span class=\"h1\">DIAGNOSIS</span></p><p class=\"headingAnchor\" id=\"H2019966297\"><span class=\"h2\">Clinical approach</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of tuberculous pleural effusion should be suspected in patients with pleural effusion and relevant epidemiologic risk factors for tuberculosis (TB) infection (these include prior history of TB infection, known or possible TB exposure, <span class=\"nowrap\">and/or</span> past or present residence in or travel to an area where TB is endemic). (See <a href=\"topic.htm?path=epidemiology-of-tuberculosis\" class=\"medical medical_review\">&quot;Epidemiology of tuberculosis&quot;</a>.)</p><p>The diagnosis of tuberculous pleural effusion may be definitively established via demonstration of <em>Mycobacterium tuberculosis</em> in pleural fluid or a pleural biopsy specimen [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/1,6\" class=\"abstract_t\">1,6</a>].</p><p>It is reasonable to make a presumptive diagnosis of TB without pathologic confirmation in the following scenarios:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a patient with an established diagnosis of pulmonary TB without <span class=\"nowrap\">signs/symptoms</span> that raise suspicion for an alternative cause for pleural effusion (such as malignancy) (see <a href=\"#H4053558263\" class=\"local\">'Differential diagnosis'</a> below)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the setting of high clinical suspicion for tuberculosis, pleural fluid analysis with lymphocytic-to-neutrophil ratio &gt;0.75 and adenosine deaminase (ADA) &gt;40 <span class=\"nowrap\">units/L,</span> or by demonstration of one or more caseating granulomas on pleural biopsy [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/1,2,24,25\" class=\"abstract_t\">1,2,24,25</a>] (see <a href=\"#H3577801\" class=\"local\">'Pleural fluid analysis'</a> below and <a href=\"#H5532816\" class=\"local\">'Pleural biopsy'</a> below)</p><p/><p>The initial evaluation of patients with suspected tuberculous pleural effusion should include diagnostic evaluation for pulmonary TB, beginning with sputum collection for <span class=\"nowrap\">smear/culture</span> for acid-fast bacilli and nucleic acid amplification test. (See <a href=\"topic.htm?path=diagnosis-of-pulmonary-tuberculosis-in-adults\" class=\"medical medical_review\">&quot;Diagnosis of pulmonary tuberculosis in adults&quot;</a>.)</p><p>Diagnostic thoracentesis is warranted in the following circumstances (see <a href=\"#H3577801\" class=\"local\">'Pleural fluid analysis'</a> below):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Suspected tuberculous pleural effusion in the absence of an established diagnosis of pulmonary TB (via sputum or other studies)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diagnosis of pulmonary TB established (via sputum or other studies) but additional etiology for pleural effusion (such as malignancy) suspected clinically</p><p/><p>Pleural biopsy is warranted if the above circumstances persist and the pleural fluid ADA level is &lt;40 <span class=\"nowrap\">units/L</span> <span class=\"nowrap\">and/or</span> pleural fluid evaluation is otherwise not diagnostic; the yield for mycobacterial culture of pleural tissue is higher than for pleural fluid. Given the low microbiologic-confirmatory yield from pleural fluid alone and the length of time that may be required for growth in culture (up to eight weeks), pursuit of pleural biopsy early in the diagnostic evaluation may be warranted, especially in complex patients with broad differential diagnosis or suspected drug resistance. (See <a href=\"#H5532816\" class=\"local\">'Pleural biopsy'</a> below.)</p><p>Patients with tuberculous pleural effusion should undergo diagnostic testing for HIV infection. (See <a href=\"topic.htm?path=acute-and-early-hiv-infection-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Acute and early HIV infection: Clinical manifestations and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3577801\"><span class=\"h2\">Pleural fluid analysis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Indications for thoracentesis are described above. (See <a href=\"#H2019966297\" class=\"local\">'Clinical approach'</a> above.)</p><p>Pleural fluid should be sent for the following studies: cell count, protein, glucose, pH, lactate dehydrogenase (LDH), acid-fast bacilli (AFB) smear and culture, Gram stain and culture, and ADA level (if the effusion is lymphocyte predominant) [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/1\" class=\"abstract_t\">1</a>]. Confirmation of the diagnosis of tuberculosis requires growth in culture, which may take up to eight weeks. (See <a href=\"topic.htm?path=diagnosis-of-pulmonary-tuberculosis-in-adults\" class=\"medical medical_review\">&quot;Diagnosis of pulmonary tuberculosis in adults&quot;</a>.)</p><p>Tuberculous pleural effusion is an exudative, lymphocyte-predominant pleural effusion, usually with the following characteristics [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/13,16,23,26\" class=\"abstract_t\">13,16,23,26</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Color &ndash; Straw colored [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/27\" class=\"abstract_t\">27</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Protein concentration &ndash; &gt;3.0 <span class=\"nowrap\">g/dL</span> (30 <span class=\"nowrap\">g/L)</span> [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/12,28\" class=\"abstract_t\">12,28</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>LDH &ndash; Elevated in approximately 75 percent of cases, with levels commonly exceeding 500 international <span class=\"nowrap\">units/L</span> [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/4,12,13,28\" class=\"abstract_t\">4,12,13,28</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>pH &ndash; Less than 7.40 in virtually all cases; pH &lt;7.30 is observed in about 20 percent of cases</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Glucose &ndash; Usually between 60 and 100 <span class=\"nowrap\">mg/dL</span> (3.3 and 5.6 <span class=\"nowrap\">mmol/L);</span> glucose levels below 50 <span class=\"nowrap\">mg/dL</span> (2.8 <span class=\"nowrap\">mmol/L)</span> are observed in 7 to 20 percent of effusions, and extremely low glucose concentrations (&lt;30 <span class=\"nowrap\">mg/dL</span> [1.7 <span class=\"nowrap\">mmol/L])</span> can occur occasionally [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/12,28\" class=\"abstract_t\">12,28</a>]</p><p/><p>The pleural fluid nucleated cell count is usually between 1000 and 6000 <span class=\"nowrap\">cells/mm<sup>3</sup></span> [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/13\" class=\"abstract_t\">13</a>]. It is lymphocyte predominant in 60 to 90 percent of cases and neutrophil predominant in the remaining cases [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/4,12,28\" class=\"abstract_t\">4,12,28</a>]. Neutrophils predominate in the first few days following onset of pleural inflammation; lymphocytes predominate thereafter [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/27,29,30\" class=\"abstract_t\">27,29,30</a>]. There is no significant correlation between the peripheral CD4 count and the pleural fluid cell count or composition [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/17,26\" class=\"abstract_t\">17,26</a>]. The pleural fluid rarely contains more than 5 percent mesothelial cells on the cell differential count; the laboratory may report &quot;many mesothelial cells&quot; without providing a percentage. Eosinophils are uncommon; the presence of more than 10 percent eosinophils usually excludes the diagnosis of tuberculous pleural effusion unless the patient had a pneumothorax or hemothorax near the time of pleural analysis [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/31\" class=\"abstract_t\">31</a>]. (See <a href=\"topic.htm?path=pleural-fluid-eosinophilia\" class=\"medical medical_review\">&quot;Pleural fluid eosinophilia&quot;</a>.)</p><p>The pleural fluid ADA level may be useful to establish a diagnosis of tuberculous pleural effusion, even when AFB smear and culture are negative [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/1,2,5\" class=\"abstract_t\">1,2,5</a>]. A presumptive diagnosis of tuberculous pleural effusion can be made if there is a pleural lymphocytic-to-neutrophil ratio &gt;0.75 and pleural ADA &gt;40 <span class=\"nowrap\">units/L</span>. Pleural effusions with an ADA level &lt;40 <span class=\"nowrap\">units/L</span> are rarely caused by TB; the test has high negative predictive value and is an excellent test to rule out TB [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/25\" class=\"abstract_t\">25</a>]. Elevated pleural fluid ADA levels can occur in other conditions besides TB infection. Some studies suggest that an ADA level &gt;45 to 60 <span class=\"nowrap\">units/L</span> is 100 percent sensitive and up to 97 percent specific for tuberculous pleural effusion [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/13,26,32-37\" class=\"abstract_t\">13,26,32-37</a>]. In one study including 548 tuberculous pleural effusions in HIV-seronegative patients compared with a control group (including malignant pleural effusion, <span class=\"nowrap\">parapneumonic/empyema,</span> miscellaneous pleural effusion, and transudative pleural effusion), pleural fluid analysis was diagnostic of tuberculous pleural effusion if all of the following criteria were met: pleural fluid protein &gt;5.0 <span class=\"nowrap\">g/dL,</span> pleural fluid lymphocyte count &gt;80 percent, and pleural fluid ADA level &gt;45 <span class=\"nowrap\">units/L</span> [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/24\" class=\"abstract_t\">24</a>]. Among HIV-infected patients, one study noted an ADA cutoff level of 60 <span class=\"nowrap\">units/L</span> in HIV-infected patients, provided a sensitivity and specificity of 95 and 96 percent, respectively [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/26,38,39\" class=\"abstract_t\">26,38,39</a>]. (See <a href=\"#H4053558263\" class=\"local\">'Differential diagnosis'</a> below.)</p><p>Pleural fluid AFB cultures are positive in fewer than 20 to 30 percent of HIV-uninfected patients [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/6\" class=\"abstract_t\">6</a>]. Patients with HIV infection may present with a greater burden of organisms than HIV-uninfected patients; in HIV-infected patients with CD4 count less than 100 <span class=\"nowrap\">cells/mm<sup>3</sup>,</span> AFB cultures are positive in approximately 50 percent of cases [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/40-42\" class=\"abstract_t\">40-42</a>]. Tuberculous empyema fluid is grossly purulent and usually AFB smear and culture positive [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/1\" class=\"abstract_t\">1</a>].</p><p>Nucleic acid amplification (NAA) assays approved by the US Food and Drug Administration (FDA) for use with sputum are not approved for use with pleural fluid. Some laboratories perform NAA testing of pleural fluid as a validated, &quot;off-label&quot; application of the testing platform; in such cases, the test characteristics should be reviewed with the laboratory before a clinical sample is submitted. NAA techniques for evaluation of tuberculous pleural effusion in HIV-uninfected patients appear to have high specificity but relatively low sensitivity [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/43,44\" class=\"abstract_t\">43,44</a>]. In one meta-analysis including 18 studies, the sensitivity and specificity for the Xpert <span class=\"nowrap\">MTB/RIF</span> assay (compared with culture) in pleural fluid were 46 and 99 percent, respectively [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/44\" class=\"abstract_t\">44</a>]. Among HIV-infected patients, it is reasonable to anticipate that the higher microbial burden in the pleural fluid is likely to be associated with a higher sensitivity of NAA assays (compared with HIV-uninfected patients); data are limited. (See <a href=\"topic.htm?path=diagnosis-of-pulmonary-tuberculosis-in-adults\" class=\"medical medical_review\">&quot;Diagnosis of pulmonary tuberculosis in adults&quot;</a>.)</p><p>Other assays that may be useful for supporting or excluding a diagnosis of tuberculous pleural effusion include pleural fluid interferon-gamma concentration and pleural fluid lysozyme concentrations [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/5,34,37,45-49\" class=\"abstract_t\">5,34,37,45-49</a>]. However, these tests have not been approved by the FDA for this purpose and they do not have a role in routine evaluation of suspected tuberculous pleural effusion.</p><p class=\"headingAnchor\" id=\"H5532816\"><span class=\"h2\">Pleural biopsy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Indications for pleural biopsy are described above. (See <a href=\"#H2019966297\" class=\"local\">'Clinical approach'</a> above.)</p><p>Pleural biopsy should be sent for AFB smear and culture as well as histopathological evaluation. Positive culture allows organism identification and drug susceptibility testing. Histopathology may demonstrate granulomas <span class=\"nowrap\">and/or</span> acid-fast bacilli. The presence of caseating (necrotizing) granulomas on histologic examination is virtually diagnostic of tuberculous pleural effusion. Noncaseating granulomas may also be observed; occasionally, these can be seen in other disorders as well. (See <a href=\"#H4053558263\" class=\"local\">'Differential diagnosis'</a> below.)</p><p>In HIV-uninfected patients, the diagnostic yield of pleural biopsy tissue is 60 to 95 percent [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/6,27,50,51\" class=\"abstract_t\">6,27,50,51</a>]. Culture of pleural biopsy material is positive in 40 to 80 percent of cases, and histology demonstrates granulomas in 50 to 97 percent of cases [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/6\" class=\"abstract_t\">6</a>]. In HIV-infected patients, the diagnostic yield of pleural biopsy tissue is 44 to 69 percent [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/16,17\" class=\"abstract_t\">16,17</a>]. Granulomas are observed less frequently than in HIV-uninfected patients but may be seen [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/16,17,42\" class=\"abstract_t\">16,17,42</a>].</p><p>Pleural tissue can be obtained via thoracoscopy or closed percutaneous needle biopsy. The sensitivities of these techniques are comparable with each other; needle biopsy is generally preferred in areas where tuberculous pleuritis is common [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/52,53\" class=\"abstract_t\">52,53</a>]. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-pleural-effusion-in-adults-additional-tests-for-undetermined-etiology#H9\" class=\"medical medical_review\">&quot;Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology&quot;, section on 'Pleural biopsy'</a>.)</p><p class=\"headingAnchor\" id=\"H8017296\"><span class=\"h2\">Additional evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to pleural evaluation, routine diagnostic evaluation for pulmonary TB should also be pursued; this is discussed in detail separately. (See <a href=\"topic.htm?path=diagnosis-of-pulmonary-tuberculosis-in-adults\" class=\"medical medical_review\">&quot;Diagnosis of pulmonary tuberculosis in adults&quot;</a>.)</p><p>Sputum culture is positive in 20 to 50 percent of HIV-uninfected patients with pleural effusion; positive sputum culture is more likely in the setting of concomitant parenchymal disease [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/4,11,12,28,54\" class=\"abstract_t\">4,11,12,28,54</a>]. In one report of 70 HIV-uninfected patients with tuberculous pleural effusions, sputum culture was positive in 89 percent of patients with parenchymal changes but only 11 percent of patients without parenchymal changes [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/54\" class=\"abstract_t\">54</a>]. The yields for induced sputum and pleural biopsy were 52 and 62 percent, respectively [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/54\" class=\"abstract_t\">54</a>]. Among HIV-infected patients, the sputum smear or culture is positive in one-third to one-half of cases [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/16,17,42\" class=\"abstract_t\">16,17,42</a>] and may even be positive when the chest radiograph is negative [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/54\" class=\"abstract_t\">54</a>].</p><p><a href=\"topic.htm?path=tuberculin-skin-test-drug-information\" class=\"drug drug_general\">Tuberculin skin test</a> (TST) and interferon-gamma release assays (IGRAs) cannot distinguish between latent tuberculosis infection and active tuberculosis disease [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/55\" class=\"abstract_t\">55</a>]. Older series reported almost uniformly positive TST results in patients with tuberculous pleural effusions; subsequent reports have observed false-negative tests in 7 to 30 percent of patients [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/4,12\" class=\"abstract_t\">4,12</a>]. Many HIV-uninfected patients with tuberculous pleural effusion and an initially negative TST have a positive TST if retested two months later. One possible explanation for the initial negative TST is suppression of sensitized T cells in the peripheral circulation and skin by circulating adherent mononuclear cells (chiefly monocytes, not classic CD8 suppressor cells); these monocytes are known to suppress antigen-induced lymphocyte blastogenesis and the production of interleukin 2. Among HIV-infected patients with tuberculous pleural effusion, the tuberculin skin test is positive in 20 to 64 percent of cases [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/16,17,23,42\" class=\"abstract_t\">16,17,23,42</a>].</p><p>The use of IGRAs on pleural fluid for the diagnosis of tuberculous pleural effusion lacks sufficient sensitivity and specificity for diagnostic use. One meta-analysis evaluating the diagnostic performance of blood and pleural fluid&ndash;based IGRAs in tuberculous pleural effusion noted pooled sensitivity and specificity for blood assays of 77 percent (95% CI 0.71 to 0.83) and 71 percent (95% CI 0.65 to 0.76), respectively; the pooled sensitivity and specificity for the pleural fluid assays were 72 percent (95% CI 0.55 to 0.84) and 78 percent (95% CI 0.65 to 0.87), respectively [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/56\" class=\"abstract_t\">56</a>]. (See <a href=\"topic.htm?path=use-of-interferon-gamma-release-assays-for-diagnosis-of-latent-tuberculosis-infection-tuberculosis-screening-in-adults\" class=\"medical medical_review\">&quot;Use of interferon-gamma release assays for diagnosis of latent tuberculosis infection (tuberculosis screening) in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4053558263\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis for tuberculous pleural effusion includes other causes of exudative pleural effusion (<a href=\"image.htm?imageKey=PULM%2F54055\" class=\"graphic graphic_table graphicRef54055 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/57\" class=\"abstract_t\">57</a>]. Many may be suspected clinically, and some can be confirmed by pleural fluid analysis (<a href=\"image.htm?imageKey=PULM%2F50027\" class=\"graphic graphic_table graphicRef50027 \">table 2</a>).</p><p>The following are the common causes of nontuberculous pleural effusions:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malignant pleural effusion &ndash; The diagnosis of malignant pleural effusion may be established via pleural fluid cytology. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing\" class=\"medical medical_review\">&quot;Diagnostic evaluation of a pleural effusion in adults: Initial testing&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Congestive heart failure &ndash; The diagnosis of congestive heart failure may be established via echocardiography and other studies. (See <a href=\"topic.htm?path=evaluation-of-the-patient-with-suspected-heart-failure\" class=\"medical medical_review\">&quot;Evaluation of the patient with suspected heart failure&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Parapneumonic effusion or empyema &ndash; Parapneumonic effusion or empyema may be caused by bacterial infection; the diagnosis may be established by bacterial culture. (See <a href=\"topic.htm?path=parapneumonic-effusion-and-empyema-in-adults\" class=\"medical medical_review\">&quot;Parapneumonic effusion and empyema in adults&quot;</a>.)</p><p/><p>Alternative causes of pleural effusions may coexist in patients with pulmonary tuberculosis.</p><p>Elevated pleural fluid adenosine deaminase (ADA) levels can occur in other conditions besides tuberculosis infection, including bacterial empyema, mesothelioma, lung cancer, lymphoma, parapneumonic effusion, and hematologic malignancies. Most assays report only the total ADA level and do not distinguish between the two principal isoenzymes, ADA-1 and ADA-2. ADA-2 is increased in tuberculous effusions, while ADA-1 is increased in other conditions [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/58\" class=\"abstract_t\">58</a>].</p><p>The differential diagnosis of caseating (necrotizing) granulomas includes fungal infection such as histoplasmosis and cryptococcus. (See <a href=\"topic.htm?path=diagnosis-and-treatment-of-pulmonary-histoplasmosis\" class=\"medical medical_review\">&quot;Diagnosis and treatment of pulmonary histoplasmosis&quot;</a> and <a href=\"topic.htm?path=cryptococcus-neoformans-infection-outside-the-central-nervous-system\" class=\"medical medical_review\">&quot;Cryptococcus neoformans infection outside the central nervous system&quot;</a>.)</p><p>The differential diagnosis of noncaseating granulomas includes sarcoidosis, rheumatoid pleuritis, and berylliosis. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-pulmonary-sarcoidosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of pulmonary sarcoidosis&quot;</a> and <a href=\"topic.htm?path=overview-of-lung-disease-associated-with-rheumatoid-arthritis\" class=\"medical medical_review\">&quot;Overview of lung disease associated with rheumatoid arthritis&quot;</a> and <a href=\"topic.htm?path=chronic-beryllium-disease-berylliosis\" class=\"medical medical_review\">&quot;Chronic beryllium disease (berylliosis)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h1\">MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Management of tuberculous pleural effusion consists of antituberculous therapy; pleural drainage is usually reserved for patients with severe symptoms.</p><p class=\"headingAnchor\" id=\"H4032127835\"><span class=\"h2\">Antituberculous therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The approach to antituberculous therapy for treatment of tuberculous pleural effusion is the same as the approach to treatment of active pulmonary tuberculosis (TB); this is discussed in detail separately. (See <a href=\"topic.htm?path=treatment-of-drug-susceptible-pulmonary-tuberculosis-in-hiv-uninfected-adults\" class=\"medical medical_review\">&quot;Treatment of drug-susceptible pulmonary tuberculosis in HIV-uninfected adults&quot;</a> and <a href=\"topic.htm?path=treatment-of-pulmonary-tuberculosis-in-hiv-infected-adults-initiation-of-therapy\" class=\"medical medical_review\">&quot;Treatment of pulmonary tuberculosis in HIV-infected adults: Initiation of therapy&quot;</a>.)</p><p>In the absence of definitive diagnosis, presumptive antituberculous therapy is warranted for patients with epidemiologic risk factors for TB infection and supportive diagnostic studies in the absence of an alternative diagnosis. As an example, this includes patients with exudative pleural effusion with lymphocyte predominance, elevated pleural ADA level (&gt;40 <span class=\"nowrap\">units/L),</span> low pleural fluid glucose level, negative pleural fluid cytology, and supporting pathology on pleural biopsy. (See <a href=\"#H3577801\" class=\"local\">'Pleural fluid analysis'</a> above.)</p><p>With appropriate therapy, most patients defervesce within two weeks; in most cases, pleural fluid is resorbed within six weeks. However, some patients take up to two months to defervesce, and fluid resorption may take up to four months.</p><p>Among HIV-infected patients, a paradoxical worsening of signs and symptoms may be observed in the first months following initiation of antiretroviral therapy; this is known as the immune reconstitution inflammatory syndrome (IRIS). (See <a href=\"topic.htm?path=immune-reconstitution-inflammatory-syndrome#H9\" class=\"medical medical_review\">&quot;Immune reconstitution inflammatory syndrome&quot;, section on 'IRIS associated with mycobacterial infections'</a>.)</p><p>Data are insufficient to support routine adjunctive use of corticosteroids for tuberculous pleural effusions [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/2,59\" class=\"abstract_t\">2,59</a>]. Administration of corticosteroids may shorten the duration of fever and time to fluid resorption, although the precise risks and benefits of corticosteroids have not been well defined [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/60,61\" class=\"abstract_t\">60,61</a>]. No difference in mortality was observed in a randomized trial including 197 HIV-infected patients with tuberculous pleural effusion treated with or without a <a href=\"topic.htm?path=prednisolone-drug-information\" class=\"drug drug_general\">prednisolone</a> taper in conjunction with antituberculous therapy [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/62\" class=\"abstract_t\">62</a>].</p><p>Residual pleural thickening can occur in up to 50 percent of patients [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/17,63-67\" class=\"abstract_t\">17,63-67</a>]. In one study including 56 HIV-uninfected patients with tuberculous pleural effusion, residual pleural thickening following completion of medical therapy was more likely among those with initial pleural fluid analysis notable for relatively low pH, low glucose concentration, high lysozyme concentration, and high tumor necrosis factor-alpha concentration [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/68\" class=\"abstract_t\">68</a>].</p><p class=\"headingAnchor\" id=\"H3891590395\"><span class=\"h2\">Pleural drainage</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Therapeutic thoracentesis is reasonable if the effusion is causing dyspnea; otherwise, routine complete drainage of pleural fluid at the time of diagnosis does not appear to affect long-term outcomes [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/65\" class=\"abstract_t\">65</a>]. This was demonstrated in a randomized trial including 61 patients with newly diagnosed tuberculous pleural effusion treated with antituberculous therapy with or without catheter drainage [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/63\" class=\"abstract_t\">63</a>]. Drainage was associated with more rapid resolution of dyspnea (four versus eight days), although after the first week there were no differences in symptoms between groups during the 24-week follow-up period. Pulmonary function and the degree of residual pleural thickening on chest radiography were the same in both groups at the conclusion of the trial.</p><p>Data are insufficient to support routine use of intrapleural fibrinolytic agents for management of loculated tuberculous effusion; the role of these agents requires further study. Issues related to their use is discussed further separately. (See <a href=\"topic.htm?path=parapneumonic-effusion-and-empyema-in-adults#H12\" class=\"medical medical_review\">&quot;Parapneumonic effusion and empyema in adults&quot;, section on 'Management'</a>.)</p><p>Patients with tuberculous empyema may require decortication [<a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/69\" class=\"abstract_t\">69</a>]. Issues related to management of empyema are discussed further separately. (See <a href=\"topic.htm?path=parapneumonic-effusion-and-empyema-in-adults#H15\" class=\"medical medical_review\">&quot;Parapneumonic effusion and empyema in adults&quot;, section on 'Empyema'</a>.)</p><p class=\"headingAnchor\" id=\"H4695691\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with tuberculous pleural effusion usually have an acute febrile illness with nonproductive cough and pleuritic chest pain. Night sweats, chills, weakness, dyspnea, and weight loss can also occur. Computed tomography is more sensitive than chest radiography; it demonstrates parenchymal disease in over 80 percent of cases. (See <a href=\"#H3576050\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of tuberculous pleural effusion should be suspected in patients with pleural effusion and relevant epidemiologic risk factors for tuberculosis (TB) infection (these include prior history of TB infection, known or possible TB exposure, <span class=\"nowrap\">and/or</span> past or present residence in or travel to an area where TB is endemic). (See <a href=\"#H2019966297\" class=\"local\">'Clinical approach'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of tuberculous pleural effusion may be definitively established via demonstration of <em>Mycobacterium tuberculosis</em> in pleural fluid or a pleural biopsy specimen. In the setting of high clinical suspicion for tuberculosis, a presumptive diagnosis of tuberculous pleural effusion may be established in the setting of pleural fluid analysis with lymphocytic-to-neutrophil ratio &gt;0.75 and adenosine deaminase (ADA) &gt;40 <span class=\"nowrap\">units/L</span> or by demonstration of one or more caseating granulomas on pleural biopsy. (See <a href=\"#H2019966297\" class=\"local\">'Clinical approach'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Thoracentesis is warranted in the following circumstances (see <a href=\"#H2019966297\" class=\"local\">'Clinical approach'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Suspected tuberculous pleural effusion in the absence of an established diagnosis of pulmonary TB (via sputum or other studies)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Diagnosis of pulmonary TB established (via sputum or other studies) but additional etiology for pleural effusion (such as malignancy) suspected clinically</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural fluid should be sent for the following studies: cell count, protein, glucose, pH, lactate dehydrogenase (LDH), acid-fast bacilli (AFB) smear and culture, Gram stain and culture, and ADA level (if the effusion is lymphocyte predominant). Confirmation of the diagnosis of tuberculosis requires growth in culture, which may take up to eight weeks. (See <a href=\"#H3577801\" class=\"local\">'Pleural fluid analysis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural biopsy is warranted if the pleural fluid ADA level is &lt;40 <span class=\"nowrap\">units/L</span> <span class=\"nowrap\">and/or</span> pleural fluid evaluation is otherwise not diagnostic. Pleural biopsy should be sent for AFB smear and culture as well as histopathologic evaluation. Histopathology may demonstrate granulomas <span class=\"nowrap\">and/or</span> acid-fast bacilli. The presence of caseating (necrotizing) granulomas on histologic examination is virtually diagnostic of tuberculous pleural effusion. (See <a href=\"#H5532816\" class=\"local\">'Pleural biopsy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The approach to antituberculous therapy for treatment of tuberculous pleural effusion is the same as the approach to treatment of active pulmonary TB; this is discussed in detail separately. (See <a href=\"topic.htm?path=treatment-of-drug-susceptible-pulmonary-tuberculosis-in-hiv-uninfected-adults\" class=\"medical medical_review\">&quot;Treatment of drug-susceptible pulmonary tuberculosis in HIV-uninfected adults&quot;</a> and <a href=\"topic.htm?path=treatment-of-pulmonary-tuberculosis-in-hiv-infected-adults-initiation-of-therapy\" class=\"medical medical_review\">&quot;Treatment of pulmonary tuberculosis in HIV-infected adults: Initiation of therapy&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the absence of definitive diagnosis, presumptive antituberculous therapy is warranted for patients with epidemiologic risk factors for TB infection and supportive diagnostic studies in the absence of an alternative diagnosis. (See <a href=\"#H4032127835\" class=\"local\">'Antituberculous therapy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Therapeutic thoracentesis is reasonable if the effusion is causing dyspnea; otherwise, routine complete drainage of pleural fluid at the time of diagnosis does not appear to affect long-term outcomes. (See <a href=\"#H3891590395\" class=\"local\">'Pleural drainage'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H660741\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge Steven Sahn, MD, who contributed to an earlier version of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/1\" class=\"nounderline abstract_t\">Zhai K, Lu Y, Shi HZ. Tuberculous pleural effusion. J Thorac Dis 2016; 8:E486.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/2\" class=\"nounderline abstract_t\">Light RW. Update on tuberculous pleural effusion. Respirology 2010; 15:451.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/3\" class=\"nounderline abstract_t\">Baumann MH, Nolan R, Petrini M, et al. Pleural tuberculosis in the United States: incidence and drug resistance. Chest 2007; 131:1125.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/4\" class=\"nounderline abstract_t\">Seibert AF, Haynes J Jr, Middleton R, Bass JB Jr. Tuberculous pleural effusion. Twenty-year experience. Chest 1991; 99:883.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/5\" class=\"nounderline abstract_t\">Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis 2017; 64:e1.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/6\" class=\"nounderline abstract_t\">Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 2007; 131:880.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/7\" class=\"nounderline abstract_t\">Torgersen J, Dorman SE, Baruch N, et al. Molecular epidemiology of pleural and other extrapulmonary tuberculosis: a Maryland state review. Clin Infect Dis 2006; 42:1375.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/8\" class=\"nounderline abstract_t\">Kim HJ, Lee HJ, Kwon SY, et al. The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis. Chest 2006; 129:1253.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/9\" class=\"nounderline abstract_t\">Merino JM, Carpintero I, Alvarez T, et al. Tuberculous pleural effusion in children. Chest 1999; 115:26.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/10\" class=\"nounderline abstract_t\">Leibowitz S, Kennedy L, Lessof MH. The tuberculin reaction in the pleural cavity and its suppression by antilymphocyte serum. Br J Exp Pathol 1973; 54:152.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/11\" class=\"nounderline abstract_t\">STEAD WW, EICHENHOLZ A, STAUSS HK. Operative and pathologic findings in twenty-four patients with syndrome of idiopathic pleurisy with effusion, presumably tuberculous. Am Rev Tuberc 1955; 71:473.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/12\" class=\"nounderline abstract_t\">Berger HW, Mejia E. Tuberculous pleurisy. Chest 1973; 63:88.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/13\" class=\"nounderline abstract_t\">Vald&eacute;s L, Alvarez D, San Jos&eacute; E, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med 1998; 158:2017.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/14\" class=\"nounderline abstract_t\">Frye MD, Pozsik CJ, Sahn SA. Tuberculous pleurisy is more common in AIDS than in non-AIDS patients with tuberculosis. Chest 1997; 112:393.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/15\" class=\"nounderline abstract_t\">Tshibwabwa-Tumba E, Mwinga A, Pobee JO, Zumla A. Radiological features of pulmonary tuberculosis in 963 HIV-infected adults at three Central African Hospitals. Clin Radiol 1997; 52:837.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/16\" class=\"nounderline abstract_t\">Relkin F, Aranda CP, Garay SM, et al. Pleural tuberculosis and HIV infection. Chest 1994; 105:1338.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/17\" class=\"nounderline abstract_t\">Frye MD, Pozsik CJ, Sahn SA. Tuberculous pleuritis and HIV disease. Chest 1995; 108:102S.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/18\" class=\"nounderline abstract_t\">Hulnick DH, Naidich DP, McCauley DI. Pleural tuberculosis evaluated by computed tomography. Radiology 1983; 149:759.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/19\" class=\"nounderline abstract_t\">Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161:1376.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/20\" class=\"nounderline abstract_t\">Sahn SA, Iseman MD. Tuberculous empyema. Semin Respir Infect 1999; 14:82.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/21\" class=\"nounderline abstract_t\">Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999; 340:367.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/22\" class=\"nounderline abstract_t\">Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 326:231.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/23\" class=\"nounderline abstract_t\">Kitinya JN, Richter C, Perenboom R, et al. Influence of HIV status on pathological changes in tuberculous pleuritis. Tuber Lung Dis 1994; 75:195.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/24\" class=\"nounderline abstract_t\">Sahn SA, Huggins JT, San Jos&eacute; ME, et al. Can tuberculous pleural effusions be diagnosed by pleural fluid analysis alone? Int J Tuberc Lung Dis 2013; 17:787.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/25\" class=\"nounderline abstract_t\">Jim&eacute;nez Castro D, D&iacute;az Nuevo G, P&eacute;rez-Rodr&iacute;guez E, Light RW. Diagnostic value of adenosine deaminase in nontuberculous lymphocytic pleural effusions. Eur Respir J 2003; 21:220.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/26\" class=\"nounderline abstract_t\">Riantawan P, Chaowalit P, Wongsangiem M, Rojanaraweewong P. Diagnostic value of pleural fluid adenosine deaminase in tuberculous pleuritis with reference to HIV coinfection and a Bayesian analysis. Chest 1999; 116:97.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/27\" class=\"nounderline abstract_t\">Levine H, Metzger W, Lacera D, Kay L. Diagnosis of tuberculous pleurisy by culture of pleural biopsy specimen. Arch Intern Med 1970; 126:269.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/28\" class=\"nounderline abstract_t\">Epstein DM, Kline LR, Albelda SM, Miller WT. Tuberculous pleural effusions. Chest 1987; 91:106.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/29\" class=\"nounderline abstract_t\">Antony VB, Repine JE, Harada RN, et al. Inflammatory responses in experimental tuberculosis pleurisy. Acta Cytol 1983; 27:355.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/30\" class=\"nounderline abstract_t\">Antony VB, Sahn SA, Antony AC, Repine JE. Bacillus Calmette-Gu&eacute;rin-stimulated neutrophils release chemotaxins for monocytes in rabbit pleural spaces and in vitro. J Clin Invest 1985; 76:1514.</a></li><li class=\"breakAll\">Light RW. Chapter 10. In: Pleural Diseases, 2d ed, Lea &amp; Febiger, Philadelphia 1990.</li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/32\" class=\"nounderline abstract_t\">Piras MA, Gakis C, Budroni M, Andreoni G. Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis. Br Med J 1978; 2:1751.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/33\" class=\"nounderline abstract_t\">Oca&ntilde;a I, Martinez-Vazquez JM, Segura RM, et al. Adenosine deaminase in pleural fluids. Test for diagnosis of tuberculous pleural effusion. Chest 1983; 84:51.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/34\" class=\"nounderline abstract_t\">Vald&eacute;s L, San Jos&eacute; E, Alvarez D, et al. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest 1993; 103:458.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/35\" class=\"nounderline abstract_t\">Orriols R, Coloma R, Ferrer J, et al. Adenosine deaminase in tuberculous pleural effusion. Chest 1994; 106:1633.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/36\" class=\"nounderline abstract_t\">Ba&ntilde;ales JL, Pineda PR, Fitzgerald JM, et al. Adenosine deaminase in the diagnosis of tuberculous pleural effusions. A report of 218 patients and review of the literature. Chest 1991; 99:355.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/37\" class=\"nounderline abstract_t\">Villegas MV, Labrada LA, Saravia NG. Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuberculosis. Chest 2000; 118:1355.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/38\" class=\"nounderline abstract_t\">Baba K, Hoosen AA, Langeland N, Dyrhol-Riise AM. Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts. PLoS One 2008; 3:e2788.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/39\" class=\"nounderline abstract_t\">Aljohaney A, Amjadi K, Alvarez GG. A systematic review of the epidemiology, immunopathogenesis, diagnosis, and treatment of pleural TB in HIV-infected patients. Clin Dev Immunol 2012; 2012:842045.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/40\" class=\"nounderline abstract_t\">Heyderman RS, Makunike R, Muza T, et al. Pleural tuberculosis in Harare, Zimbabwe: the relationship between human immunodeficiency virus, CD4 lymphocyte count, granuloma formation and disseminated disease. Trop Med Int Health 1998; 3:14.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/41\" class=\"nounderline abstract_t\">Richter C, Perenboom R, Mtoni I, et al. Clinical features of HIV-seropositive and HIV-seronegative patients with tuberculous pleural effusion in Dar es Salaam, Tanzania. Chest 1994; 106:1471.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/42\" class=\"nounderline abstract_t\">Gil V, Cordero PJ, Greses JV, Soler JJ. Pleural tuberculosis in HIV-infected patients. Chest 1995; 107:1775.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/43\" class=\"nounderline abstract_t\">Trajman A, da Silva Santos Kleiz de Oliveira EF, Bastos ML, et al. Accuracy of polimerase chain reaction for the diagnosis of pleural tuberculosis. Respir Med 2014; 108:918.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/44\" class=\"nounderline abstract_t\">Denkinger CM, Schumacher SG, Boehme CC, et al. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J 2014; 44:435.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/45\" class=\"nounderline abstract_t\">Hiraki A, Aoe K, Eda R, et al. Comparison of six biological markers for the diagnosis of tuberculous pleuritis. Chest 2004; 125:987.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/46\" class=\"nounderline abstract_t\">Aoe K, Hiraki A, Murakami T, et al. Diagnostic significance of interferon-gamma in tuberculous pleural effusions. Chest 2003; 123:740.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/47\" class=\"nounderline abstract_t\">Wongtim S, Silachamroon U, Ruxrungtham K, et al. Interferon gamma for diagnosing tuberculous pleural effusions. Thorax 1999; 54:921.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/48\" class=\"nounderline abstract_t\">Jiang J, Shi HZ, Liang QL, et al. Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis. Chest 2007; 131:1133.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/49\" class=\"nounderline abstract_t\">Verea Hernando HR, Masa Jimenez JF, Dominguez Juncal L, et al. Meaning and diagnostic value of determining the lysozyme level of pleural fluid. Chest 1987; 91:342.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/50\" class=\"nounderline abstract_t\">Kirsch CM, Kroe DM, Azzi RL, et al. The optimal number of pleural biopsy specimens for a diagnosis of tuberculous pleurisy. Chest 1997; 112:702.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/51\" class=\"nounderline abstract_t\">Sahn SA. State of the art. The pleura. Am Rev Respir Dis 1988; 138:184.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/52\" class=\"nounderline abstract_t\">Diacon AH, Van de Wal BW, Wyser C, et al. Diagnostic tools in tuberculous pleurisy: a direct comparative study. Eur Respir J 2003; 22:589.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/53\" class=\"nounderline abstract_t\">Emad A, Rezaian GR. Diagnostic value of closed percutaneous pleural biopsy vs pleuroscopy in suspected malignant pleural effusion or tuberculous pleurisy in a region with a high incidence of tuberculosis: a comparative, age-dependent study. Respir Med 1998; 92:488.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/54\" class=\"nounderline abstract_t\">Conde MB, Loivos AC, Rezende VM, et al. Yield of sputum induction in the diagnosis of pleural tuberculosis. Am J Respir Crit Care Med 2003; 167:723.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/55\" class=\"nounderline abstract_t\">Losi M, Bossink A, Codecasa L, et al. Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J 2007; 30:1173.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/56\" class=\"nounderline abstract_t\">Aggarwal AN, Agarwal R, Gupta D, et al. Interferon Gamma Release Assays for Diagnosis of Pleural Tuberculosis: a Systematic Review and Meta-Analysis. J Clin Microbiol 2015; 53:2451.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/57\" class=\"nounderline abstract_t\">Porcel JM, Azzopardi M, Koegelenberg CF, et al. The diagnosis of pleural effusions. Expert Rev Respir Med 2015; 9:801.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/58\" class=\"nounderline abstract_t\">Gakis C. Adenosine deaminase in pleural effusions. Chest 1995; 107:1772.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/59\" class=\"nounderline abstract_t\">Ryan H, Yoo J, Darsini P. Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev 2017; 3:CD001876.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/60\" class=\"nounderline abstract_t\">Lee CH, Wang WJ, Lan RS, et al. Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study. Chest 1988; 94:1256.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/61\" class=\"nounderline abstract_t\">Matchaba PT, Volmink J. Steroids for treating tuberculous pleurisy. Cochrane Database Syst Rev 2000; :CD001876.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/62\" class=\"nounderline abstract_t\">Elliott AM, Luzze H, Quigley MA, et al. A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis. J Infect Dis 2004; 190:869.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/63\" class=\"nounderline abstract_t\">Lai YF, Chao TY, Wang YH, Lin AS. Pigtail drainage in the treatment of tuberculous pleural effusions: a randomised study. Thorax 2003; 58:149.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/64\" class=\"nounderline abstract_t\">Barbas CS, Cukier A, de Varvalho CR, et al. The relationship between pleural fluid findings and the development of pleural thickening in patients with pleural tuberculosis. Chest 1991; 100:1264.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/65\" class=\"nounderline abstract_t\">Bhuniya S, Arunabha DC, Choudhury S, et al. Role of therapeutic thoracentesis in tuberculous pleural effusion. Ann Thorac Med 2012; 7:215.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/66\" class=\"nounderline abstract_t\">Bolliger CT, de Kock MA. Influence of a fibrothorax on the flow/volume curve. Respiration 1988; 54:197.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/67\" class=\"nounderline abstract_t\">Candela A, Andujar J, Hern&aacute;ndez L, et al. Functional sequelae of tuberculous pleurisy in patients correctly treated. Chest 2003; 123:1996.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/68\" class=\"nounderline abstract_t\">de Pablo A, Villena V, Echave-Sustaeta J, Encuentra AL. Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis? Chest 1997; 112:1293.</a></li><li><a href=\"https://www.uptodate.com/contents/tuberculous-pleural-effusion/abstract/69\" class=\"nounderline abstract_t\">Chen B, Zhang J, Ye Z, et al. Outcomes of Video-Assisted Thoracic Surgical Decortication in 274 Patients with Tuberculous Empyema. Ann Thorac Cardiovasc Surg 2015; 21:223.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 8012 Version 18.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H4695691\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H3576050\" id=\"outline-link-H3576050\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H2891054917\" id=\"outline-link-H2891054917\">Overview</a></li><li><a href=\"#H3345958506\" id=\"outline-link-H3345958506\">HIV coinfection</a></li></ul></li><li><a href=\"#H3577153\" id=\"outline-link-H3577153\">DIAGNOSIS</a><ul><li><a href=\"#H2019966297\" id=\"outline-link-H2019966297\">Clinical approach</a></li><li><a href=\"#H3577801\" id=\"outline-link-H3577801\">Pleural fluid analysis</a></li><li><a href=\"#H5532816\" id=\"outline-link-H5532816\">Pleural biopsy</a></li><li><a href=\"#H8017296\" id=\"outline-link-H8017296\">Additional evaluation</a></li></ul></li><li><a href=\"#H4053558263\" id=\"outline-link-H4053558263\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">MANAGEMENT</a><ul><li><a href=\"#H4032127835\" id=\"outline-link-H4032127835\">Antituberculous therapy</a></li><li><a href=\"#H3891590395\" id=\"outline-link-H3891590395\">Pleural drainage</a></li></ul></li><li><a href=\"#H4695691\" id=\"outline-link-H4695691\">SUMMARY</a></li><li><a href=\"#H660741\" id=\"outline-link-H660741\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/8012|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/63772\" class=\"graphic graphic_diagnosticimage\">- TB pleural effusion CT</a></li><li><a href=\"image.htm?imageKey=ID/106792\" class=\"graphic graphic_diagnosticimage\">- CT tuberculous empyema</a></li></ul></li><li><div id=\"ID/8012|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/54055\" class=\"graphic graphic_table\">- Exudative pleural effusions</a></li><li><a href=\"image.htm?imageKey=PULM/50027\" class=\"graphic graphic_table\">- Dx by pleural fluid analysis</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-and-early-hiv-infection-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Acute and early HIV infection: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chronic-beryllium-disease-berylliosis\" class=\"medical medical_review\">Chronic beryllium disease (berylliosis)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-pulmonary-sarcoidosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of pulmonary sarcoidosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cryptococcus-neoformans-infection-outside-the-central-nervous-system\" class=\"medical medical_review\">Cryptococcus neoformans infection outside the central nervous system</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-treatment-of-pulmonary-histoplasmosis\" class=\"medical medical_review\">Diagnosis and treatment of pulmonary histoplasmosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-pulmonary-tuberculosis-in-adults\" class=\"medical medical_review\">Diagnosis of pulmonary tuberculosis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing\" class=\"medical medical_review\">Diagnostic evaluation of a pleural effusion in adults: Initial testing</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-evaluation-of-pleural-effusion-in-adults-additional-tests-for-undetermined-etiology\" class=\"medical medical_review\">Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-of-tuberculosis\" class=\"medical medical_review\">Epidemiology of tuberculosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-the-patient-with-suspected-heart-failure\" class=\"medical medical_review\">Evaluation of the patient with suspected heart failure</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immune-reconstitution-inflammatory-syndrome\" class=\"medical medical_review\">Immune reconstitution inflammatory syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-lung-disease-associated-with-rheumatoid-arthritis\" class=\"medical medical_review\">Overview of lung disease associated with rheumatoid arthritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=parapneumonic-effusion-and-empyema-in-adults\" class=\"medical medical_review\">Parapneumonic effusion and empyema in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pleural-fluid-eosinophilia\" class=\"medical medical_review\">Pleural fluid eosinophilia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-drug-susceptible-pulmonary-tuberculosis-in-hiv-uninfected-adults\" class=\"medical medical_review\">Treatment of drug-susceptible pulmonary tuberculosis in HIV-uninfected adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-pulmonary-tuberculosis-in-hiv-infected-adults-initiation-of-therapy\" class=\"medical medical_review\">Treatment of pulmonary tuberculosis in HIV-infected adults: Initiation of therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=use-of-interferon-gamma-release-assays-for-diagnosis-of-latent-tuberculosis-infection-tuberculosis-screening-in-adults\" class=\"medical medical_review\">Use of interferon-gamma release assays for diagnosis of latent tuberculosis infection (tuberculosis screening) in adults</a></li></ul></div></div>","javascript":null}